معرفی
Elizabeth Sage is a medical researcher with significant contributions to both respiratory medicine and medical imaging fields. Her work spans over a decade, connecting early research in pulmonary imaging techniques with more recent investigations into the immunological aspects of COVID-19.
Her research interests demonstrate a clear trajectory from specialized medical imaging techniques to broader clinical applications in respiratory diseases. The fingerprint analysis of her work shows strong connections to COVID-19 research (100%), Dyspnea studies (100%), Post-COVID conditions (54%), and Lung medicine (50%). Additional significant areas include Sleep Disorders (50%) and Pentetic Acid pharmacology (50%), reflecting her dual expertise in both clinical respiratory medicine and pharmaceutical imaging agents.
The evolution of her research shows a transition from highly technical medical imaging development (evident in her 2013 work on pulmonary metastases imaging) to population-level clinical studies addressing the global COVID-19 pandemic. Her recent work as part of the PHOSP-COVID Study collaborative group demonstrates involvement in large-scale, multi-center research initiatives examining long-term effects of COVID-19.
Her publication record indicates active collaboration within the UK medical research community, particularly with institutions involved in the PHOSP-COVID consortium. While specific awards aren't documented in the available information, her work has garnered significant attention with 57 total citations and media coverage across 73 news outlets for her COVID-19 related research.